Transitional Drugs 6
NHS Wales is seeking suppliers of three pharmaceutical products: Apremilast, Denosumab, and Pazopanib. The contract is worth over £12m and runs to January 2026.
- Closed8 January 2026
- Value£12m
- BuyerNHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- CategoryHealth & medical
- RegionWales
You'll want to look if you're a licensed pharmaceutical wholesaler or manufacturer with UK distribution capability for these three drugs
Might not suit a small firm
- the contract itself is a large one
Possible incumbent
Novartis, Amarox Pharma and Novumgen Ltd won the previous Transitional Drugs 4 contract in October 2025. Inferred from prior awards to this buyer, not confirmed.